Manager, Commercial Segmentation and Portfolio Operations
The Manager, Commercial Segmentation and Portfolio Operations owns the Commercial Planning & Assessment (CPM) team’s global SKU (stock keeping unit) segmentation process across all Pfizer Business Units and Therapeutic Areas. This colleague partners with Medical, Pfizer Global Supply (PGS), Commercial, Finance, and Data Governance to make sure medical designations and commercial priorities are aligned and that governance, audit, and compliance standards are met. The role also leads CPM portfolio operations, conflict-of-interest (COI) assessments for PC1 (Pfizer CentreOne) new-business opportunities, and competitive intelligence (CI) analysis that surfaces revenue-upside opportunities. It offers high visibility with senior leaders and a broad view of Pfizer’s Specialty Care portfolio.
Role Responsibilities
---------------------
1\. SKU Segmentation Governance and Execution (~35%)
- Own the end-to-end global segmentation process, accountable for delivering time-sensitive, audit-ready outcomes.
- Coordinate required actions across Medical, PGS, Commercial, and Data Governance.
- Lead the monthly Segmentation Alignment Meeting with leadership, and convene it as needed.
- Drive SOP (standard operating procedure) transitions, governance enhancements, and process optimization.
2\. Medical Partnership and Segmentation Performance (~15%)
- Act as the strategic partner to Medical, aligning medical designations with commercial business outcomes.
- Define, produce, and communicate SKU segmentation performance metrics to stakeholders and leadership.
- Use the metrics to shape decisions and recommend improvements.
3\. Portfolio Operations and Project Leadership (~30%)
- Lead operational project management for key CPM initiatives, balancing multiple priorities and holding deadlines.
- Run the cadence for CPM leadership meetings: agenda, materials, action plans, and follow-through.
- Oversee allocation tracking and reporting, the team playbook and CPM roadshow, and the team goals and capability and development tracking.
4\. Conflict of Interest (COI) Assessment (~10%)
- Lead the evaluation of PC1 new-business opportunities before contract signature. This includes research on the Active Pharmaceutical Ingredient (API), indication, presentation, and delivery mechanism.
- Assess overlap with the Pfizer portfolio and pipeline.
- Decide approval or rejection, communicate the justification to PC1, and maintain the COI decisio...
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis.